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Abstracts

SFN-rich broccoli sprouts in subjects at a high-risk of developing
psychosis may prevent the onset of psychosis at adulthood.

PM366
Three-dimensional analysis of morphological
changes in dendritic spines and mitochondria in
dentate gyrus granule cells in Schnurri-2 knockout
mice, an animal model for schizophrenia
Akito Nakao,
Fujita Health University, Japan
Abstract
Accumulating evidence suggests that morphological changes of
subcellular-scale structures such as dendritic spine and mitochondria may be involved in the pathogenesis/pathophysiology
of schizophrenia. Previously, we have proposed mice lacking
Schnurri-2 (Shn2), an MHC enhancer binding protein, as a schizophrenia model with mild chronic inflammation. In the mutants,
there are decreases in the expression level of PSD95, synaptic
marker, and increases in C1q family genes (C1qa, C1qc and C1ql2),
which are considered to mediate synapse elimination during the
postnatal development. In the present study, we analyzed threedimensional morphological changes in dendritic spines and mitochondria in dentate gyrus granule cells in Shn2 KO mice by serial
block-face scanning electron microscopy. The mutants showed
about 13% increase in spine length, and about 25% increase in
spine neck length. There were no significant differences between
Shn2 KO and wild-type mice in their spine density, volume of
spine, spine head length, or spine head diameter. The mutants
exhibited reduced complexity in mitochondrial morphology, suggesting that a balance between mitochondrial fusion and fission
is compromised in Shn2 KO mice. These morphological changes
in spines and mitochondria may be associated with functional
impairments of those subcellular-scale structures, and represent
potential endophenotype of schizophrenia.
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Abstract
Background: Maternal immune activation (MIA) during pregnancy is a risk factor for schizophrenia and may be linked to
cognitive deficits of the disorder [1, 2]. Current antipsychotics
show minimal improvement of cognitive deficits [3] and have
adverse side-effects [4]. Cannabidiol (CBD), a constituent of cannabis, possesses anti-inflammatory, antipsychotic and neuroprotective properties [5]; however, whether CBD can improve
cognition in schizophrenia is unknown. The aim of this study
was to examine effects of CBD on cognition in a MIA model of
schizophrenia.
Methods: Pregnant dams were administered either poly IC (POLY;
4mg/kg) or saline (CONT). From postnatal day 56, offspring were
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administered either vehicle (CONT+VEH, POLY+VEH) or CBD
(10 mg/kg; CONT+CBD, POLY+CBD) twice daily for 3 weeks (n=12
males, 12 females/group). Novel object recognition (NOR) and
T-maze tests were performed to assess recognition and working
memory.
Results: In the NOR test, POLY+VEH males spent significantly
less time exploring the novel object compared to CONT+VEH
counterparts (p<0.01), and in the T-maze test, POLY+VEH
males exhibited a lower number of correct entries (p<0.01 vs.
CONT+VEH). Performance of POLY+CBD males was significantly
better than POLY+VEH in both tests (p<0.05) and did not differ
from CONT+VEH (p>0.05). No differences were observed between
CONT+VEH and CONT+CBD males (p>0.05). There was no effect
of poly IC or CBD treatment on female offspring performance in
either test (p>0.05).
Conclusions: Interestingly, CBD treatment restored working
and recognition memory impairments in the poly IC model of
schizophrenia, but had no effect in control rats. These effects
were observed in male offspring, whereas females showed no
cognitive impairment. The mechanisms underlying the apparent protection in females and sensitivity in males warrant further investigation. This is the first study to examine chronic
CBD treatment effects in a MIA model, and suggests that CBD
may have sex-specific therapeutic potential for schizophreniarelated cognitive impairments.
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Abstract
Objective: Impaired glucose and energy metabolism may
play a role in the pathobiology of schizophrenia. Abnormal
brain energy metabolism has been found in animal models of

